daily digesthttp://eatg.tttp.euHIV prevention measures must include behavioral strategies to work, says APA http://eatg.tttp.eu/Global-HIV-News/Prevention/HIV-prevention-measures-must-include-behavioral-strategies-to-work-says-APATruvada alone not sufficient, given adherence and other challenges.Dangerous doseshttp://eatg.tttp.eu/Global-HIV-News/World-Policy/Dangerous-dosesFighting fraud in the global medicine supply chain. Violation of human rights and breaches of medical confidentiality by the Greek Police and Health Authorities http://eatg.tttp.eu/Global-HIV-News/World-Policy/Violation-of-human-rights-and-breaches-of-medical-confidentiality-by-the-Greek-Police-and-Health-AuthoritiesJoint news release GNP+ and NSWP.GeoVax Labs reports 2012 first quarter financial resultshttp://eatg.tttp.eu/Global-HIV-News/Prevention/GeoVax-Labs-reports-2012-first-quarter-financial-resultsData from Phase 2a preventive HIV vaccine trial expected in late 2012; Phase 1/2 therapeutic vaccine trial patient enrollment advancing; Unprecedented preclinical results with adjuvanted vaccine – new human trial opened; Comments on Gilead Science’s Truvada® prevention submission.HIV linked to risk of sudden cardiac deathhttp://eatg.tttp.eu/Global-HIV-News/Treatment/HIV-linked-to-risk-of-sudden-cardiac-deathPeople with HIV have more than four times the risk of sudden cardiac death than the general population.Cancer and higher mortality in HIV+ vs general population in Italyhttp://eatg.tttp.eu/Global-HIV-News/Treatment/Cancer-and-higher-mortality-in-HIV-vs-general-population-in-ItalyHIV-positive people in Italy continue to have a 6 times higher risk of death than the general population. And HIV-positive people with cancer have a 15 times higher risk.ART reduces TB risk, even in high-income countrieshttp://eatg.tttp.eu/Global-HIV-News/TB-Malaria/ART-reduces-TB-risk-even-in-high-income-countriesHowever, the benefit is not seen in patients who start ART at very low CD4-cell counts. Achillion: ACH-3102 receives Fast Track designation from the FDA for the treatment of chronic hepatitis Chttp://eatg.tttp.eu/Global-HIV-News/Hepatitis/Achillion-ACH-3102-receives-Fast-Track-designation-from-the-FDA-for-the-treatment-of-chronic-hepatitis-CACH-3102 is a pan-genotypic second-generation NS5A inhibitor against HCV that is currently being evaluated in a Phase 1 clinical trial.Orasure in-home HIV test gets unanimous approval recommendationhttp://eatg.tttp.eu/Global-HIV-News/Prevention/Orasure-in-home-HIV-test-gets-unanimous-approval-recommendationOrasure’s oral swab-based rapid in-home HIV test has been recommended for approval by the U.S. Food and Drug Administration’s Blood Products Advisory Committee.FDA sees benefits and risks with first over-the-counter HIV test for home usehttp://eatg.tttp.eu/Global-HIV-News/Prevention/FDA-sees-benefits-and-risks-with-first-over-the-counter-HIV-test-for-home-useThe Food and Drug Administration is considering approval of the first over-the-counter HIV test that would allow consumers to quickly test themselves for the virus at home, without medical supervision. We are losing the fight against TB, warns WHOhttp://eatg.tttp.eu/Global-HIV-News/TB-Malaria/We-are-losing-the-fight-against-TB-warns-WHOGovernments told they must act to halt spread of drug-resistant strains.USAID: Global health and child survival: Progress report to Congress 2010-2011http://eatg.tttp.eu/Global-HIV-News/World-Policy/USAID-Global-health-and-child-survival-Progress-report-to-Congress-2010-2011With prospects for ending preventable child and maternal deaths, creating an AIDS-free generation, and laying the foundations for universal health coverage, future generations will look back at this period as a turning point in the history of global health.Board of Global Fund speeds up implementation of its strategyhttp://eatg.tttp.eu/Global-HIV-News/World-Policy/Board-of-Global-Fund-speeds-up-implementation-of-its-strategyThe Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria concluded its 26th Meeting with broad agreement to direct more than $1.6 billion in available funding into effective programs that save lives, accelerating implementation of the Board’s ambitious strategy.NIH statement on HIV Vaccine Awareness Day - May 18, 2012http://eatg.tttp.eu/Global-HIV-News/Prevention/NIH-statement-on-HIV-Vaccine-Awareness-Day-May-18-2012Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.International Day Against Homophobia and Transphobiahttp://eatg.tttp.eu/Global-HIV-News/MSM/International-Day-Against-Homophobia-and-TransphobiaMessage from UNAIDS Executive Director Michel Sidibé.UNITAID: Five years of health innovation brings new approach and new medicines to developing country marketshttp://eatg.tttp.eu/Global-HIV-News/Access-to-treatment/UNITAID-Five-years-of-health-innovation-brings-new-approach-and-new-medicines-to-developing-country-marketsThrough spearheading innovative initiatives and providing financing for global health over the past five years, UNITAID has had a dramatic impact on millions of lives, using creative market approaches to increase access to treatment and diagnostics for HIV, malaria and tuberculosis.Gilead Quad tablet gets FDA committee approval nodhttp://eatg.tttp.eu/Global-HIV-News/Treatment/Gilead-Quad-tablet-gets-FDA-committee-approval-nodShould the FDA follow the recommendation of its Antiviral Drugs Advisory Committee, the drug will be the third all-in-one regimen to be approved by the agency.Canadian cohort shows viral suppression most likely with atazanavir/ritonavir-based HIV treatment after 6 monthshttp://eatg.tttp.eu/Global-HIV-News/Treatment/Canadian-cohort-shows-viral-suppression-most-likely-with-atazanavir-ritonavir-based-HIV-treatment-after-6-monthsAtazanavir/ritonavir strongest among people with a history of injecting drug use.AVAC urges FDA approval of PrEP following positive Advisory Committee recommendation; Lays out priorities to ensure access http://eatg.tttp.eu/Global-HIV-News/Prevention/AVAC-urges-FDA-approval-of-PrEP-following-positive-Advisory-Committee-recommendation-Lays-out-priorities-to-ensure-accessCiting the urgent need for new HIV prevention options to stem HIV infections, AVAC urges the FDA to issue an approval for all men and women at risk, and is calling on public health agencies, governments, advocates and funders to take action to ensure access to TDF/FTC as PrEP.New report offers a blueprint to boost research and development (R&D) for diseases of the developing worldhttp://eatg.tttp.eu/Global-HIV-News/Access-to-treatment/New-report-offers-a-blueprint-to-boost-research-and-development-R-D-for-diseases-of-the-developing-worldA new study is released reviewing initiatives to encourage research and development (R&D) for diseases such as HIV, tuberculosis, malaria and neglected tropical diseases.